See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line sample; you can sign up to receive the Connection (~every two weeks) right here. TODAY’S NEWS It's going …
Today’s Top Three in Pharma 042309
FDA extends review of AstraZeneca/BMS experimental diabetes drug Onglyza. Teva blocked from launching generic form of Lilly's Evista; also rumored to be eyeballing a purchase of …
Today’s Top Three in Pharma 040309
Avastin approved for glioblastoma. Nice results for experimental blood pressure drug from Gilead - Gilead Sciences Inc said on Thursday its experimental drug to treat patients whose high blood …
Today’s Top Three in Pharma 020309
Avastin + Tarceva = better results in lung cancer - Genentech said the trial was stopped early after an interim analysis found that combining Avastin, known generically as bevacizumab, and Tarceva, or …
Pharma News this week
Sanofi-Aventis suspends sale of Acomplia in Europe. Acomplia, an obesity drug that once looked like it would be a blockbuster for Sanofi-Aventis, is being pulled off the market in Europe. The EMEA, …
Pharma News 10_10
J&J announces leadership transition - Johnson & Johnson appointed Sheri McCoy, leader of its surgical care group, on Thursday worldwide chairman of its pharmaceuticals group, effective Jan. 1. …